Evidence map›Paper›PMID 35026139›Full record

SynthesisThe lancet. Psychiatry2022

Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.

GBD 2019 Mental Disorders Collaborators

7 registry-linked trialsAbstract readSystematic Review
In one paragraph

Synthesis in The lancet. Psychiatry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 7 registered trials, which are not on this map. Cited by 3,049 papers, 11 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3,049citing papers in PubMed, 11 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06042283 nacompletednot on this mapstarted 2023, after this paper: background citation

Assessing the Efficacy of Metacognitive Training on Depressive Symptoms, Dysfunctional Attitudes and Metacognition in Older Adults Diagnosed With Depression

TypeinterventionalSponsorIstanbul University - CerrahpasaRan2023 to 2024Enrolled50ConditionsDepression in Old AgeArmsMetacognitive Training-Silver
NCT06588270 narecruitingnot on this map

Effect of Virtual Reality-based Therapy on Negative Symptoms in People with Schizophrenia: Study Protocol for a Randomized Controlled Trial

TypeinterventionalSponsorHospital de la Florida Dra. Eloiza DiazRan2022 to 2025Enrolled102ConditionsSchizophreniaArmsVirtual Reality Therapy for the Negative Symptoms of Schizophrenia, Sham- VR
NCT06701279 not yet recruitingnot on this mapstarted 2024, after this paper: background citation

Role of Electrocardiogram Abnormalities in Prediction of Mortality in Patients With Isolated Traumatic Brain Injury

TypeobservationalSponsorAssiut UniversityRan2024 to 2027Enrolled54ConditionsTraumatic Brain Injury
NCT06837207 nanot yet recruitingnot on this mapstarted 2025, after this paper: background citation

Safety and Efficacy Study of Precise Transcranial Magnetic Stimulation for Depression Based on Individualized Functional Connectivity Localization of Orbital Frontal Cortex-habenula

TypeinterventionalSponsorXijing HospitalRan2025 to 2026Enrolled30ConditionsDepression, Transcranial Magnetic StimulationArmstranscranial magnetic stimulation
NCT06975098 nacompletednot on this mapstarted 2024, after this paper: background citation

A Journey to Balance: Development and Validation of Individualized Life Balance Intervention for Depression

TypeinterventionalSponsorChung Shan Medical UniversityRan2024 to 2025Enrolled11ConditionsDepression DisordersArmsLife balance intervention group program
NCT06978257 narecruitingnot on this mapstarted 2025, after this paper: background citation

Protocol of a Two-Arm Randomized Controlled Trial (RCT) of Digital Positive Affect Intervention Study

TypeinterventionalSponsorNational University of SingaporeRan2025 to 2029Enrolled2,400ConditionsMild to Moderate Anxiety and DepressionArmsDigital positive affect intervention (PAI), Self-monitoring intervention
NCT07048119 nacompletednot on this map

Development, Usability and Feasibility Pilot Study of a Videogame Aiming to Stimulate Cognitive and Non-cognitive Skills Among Low-income Preschoolers in Chile

TypeinterventionalSponsorUniversidad de los Andes, ChileRan2018 to 2018Enrolled317ConditionsMental Health Issue, Development, Child, Cognitive Ability, GeneralArmsJapi 1.0
3 · Its place in the literature

Who cites it

3,049 citing papers in PubMed, 11 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. International journal of qualitative studies on health and well-being · 2026
    Trial
  13. Trial
  14. Trial
  15. Trial
  16. CSF galanin and noradrenaline downregulation by psilocybin therapy in major depressive disorder.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

2,989 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

GBD 2019 Mental Disorders Collaborators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe mental disorders included in the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 were depressive disorders, anxiety disorders, bipolar disorder, schizophrenia, autism spectrum disorders, conduct disorder, attention-deficit hyperactivity disorder, eating disorders, idiopathic developmental intellectual disability, and a residual category of other mental disorders. We aimed to measure the global, regional, and national prevalence, disability-adjusted life-years (DALYS), years lived with disability (YLDs), and years of life lost (YLLs) for mental disorders from 1990 to 2019.

methodsIn this study, we assessed prevalence and burden estimates from GBD 2019 for 12 mental disorders, males and females, 23 age groups, 204 countries and territories, between 1990 and 2019. DALYs were estimated as the sum of YLDs and YLLs to premature mortality. We systematically reviewed PsycINFO, Embase, PubMed, and the Global Health Data Exchange to obtain data on prevalence, incidence, remission, duration, severity, and excess mortality for each mental disorder. These data informed a Bayesian meta-regression analysis to estimate prevalence by disorder, age, sex, year, and location. Prevalence was multiplied by corresponding disability weights to estimate YLDs. Cause-specific deaths were compiled from mortality surveillance databases. The Cause of Death Ensemble modelling strategy was used to estimate death rate by age, sex, year, and location. The death rates were multiplied by the years of life expected to be remaining at death based on a normative life expectancy to estimate YLLs. Deaths and YLLs could be calculated only for anorexia nervosa and bulimia nervosa, since these were the only mental disorders identified as underlying causes of death in GBD 2019.

findingsBetween 1990 and 2019, the global number of DALYs due to mental disorders increased from 80·8 million (95% uncertainty interval [UI] 59·5-105·9) to 125·3 million (93·0-163·2), and the proportion of global DALYs attributed to mental disorders increased from 3·1% (95% UI 2·4-3·9) to 4·9% (3·9-6·1). Age-standardised DALY rates remained largely consistent between 1990 (1581·2 DALYs [1170·9-2061·4] per 100 000 people) and 2019 (1566·2 DALYs [1160·1-2042·8] per 100 000 people). YLDs contributed to most of the mental disorder burden, with 125·3 million YLDs (95% UI 93·0-163·2; 14·6% [12·2-16·8] of global YLDs) in 2019 attributable to mental disorders. Eating disorders accounted for 17 361·5 YLLs (95% UI 15 518·5-21 459·8). Globally, the age-standardised DALY rate for mental disorders was 1426·5 (95% UI 1056·4-1869·5) per 100 000 population among males and 1703·3 (1261·5-2237·8) per 100 000 population among females. Age-standardised DALY rates were highest in Australasia, Tropical Latin America, and high-income North America.

interpretationGBD 2019 showed that mental disorders remained among the top ten leading causes of burden worldwide, with no evidence of global reduction in the burden since 1990. The estimated YLLs for mental disorders were extremely low and do not reflect premature mortality in individuals with mental disorders. Research to establish causal pathways between mental disorders and other fatal health outcomes is recommended so that this may be addressed within the GBD study. To reduce the burden of mental disorders, coordinated delivery of effective prevention and treatment programmes by governments and the global health community is imperative.

fundingBill & Melinda Gates Foundation, Australian National Health and Medical Research Council, Queensland Department of Health, Australia.

Indexed as

Disability-Adjusted Life YearsGlobal Burden of DiseaseAdolescentAdultAgedAge DistributionChildChild, PreschoolEpidemiologic StudiesFemaleGlobal HealthHumansInfantMaleMental DisordersMiddle Aged

Identifiers

PMID35026139
PMCPMC8776563

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

and 1 more above

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.